Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other hematologic neoplasm 2Myeloid 2Sarcoma 1Plasma cell 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Myelodysplastic Syndromes 160Leukemia, Myeloid, Acute 123Leukemia, Myelomonocytic, Chronic 65Leukemia 35Myeloproliferative Disorders 23Primary Myelofibrosis 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Anemia, Refractory, with Excess of Blasts 11Hematologic Neoplasms 10Myelodysplastic-Myeloproliferative Diseases 9Recurrence 8Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Neoplasms 7Lymphoma, Non-Hodgkin 6Leukemia, Biphenotypic, Acute 6Lymphoma 5Polycythemia Vera 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Myelomonocytic, Acute 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Erythroblastic, Acute 4Hematologic Diseases 4Anemia, Refractory 4Thrombocythemia, Essential 3Prostatic Neoplasms 3Neoplasm, Residual 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3

Interventions

Nivolumab 2Azacitidine 2motexafin gadolinium 1cc-486 1Tretinoin 1TTI-621 1Rituximab 1Injections 1Imatinib Mesylate 1INCB059872 1Fentanyl 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × Azacitidine × Myeloid × Clear all
NCT02712905 2025-11-04

An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

Incyte Corporation

Phase 1/2 Terminated
116 enrolled 36 charts
MyeloidOther hematologic neoplasmThoracic

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Primary Myelofibrosis, Small Cell Lung Carcinoma

NCT02223052 2020-05-12

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Celgene

Phase 1 Completed
89 enrolled
BreastCNSDermatologicGenitourinaryGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glioblastoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡